Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro
- PMID: 19579295
- DOI: 10.1681/asn.2009040444
Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro
Abstract
Some time has passed since the torrent of discussion surrounding the cardiovascular risk of pushing up hemoglobin concentrations in dialysis patients with erythropoietin. The debate here reflects a look back on the tension produced by confusing data and outcomes. Is it the target hemoglobin per se or the high doses of erythropoietin in subsets of resistant patients that is the problem? You decide.
Comment in
-
Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: con.J Am Soc Nephrol. 2009 Jul;20(7):1441-3. J Am Soc Nephrol. 2009. PMID: 19579287 No abstract available.
-
Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.J Am Soc Nephrol. 2011 Jan;22(1):1-2. doi: 10.1681/ASN.2010111133. Epub 2010 Dec 16. J Am Soc Nephrol. 2011. PMID: 21164031 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
